Supplemental material
Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Open access
1,202
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults
Sophie Marbaixa Health Economics, SNB management, Soignies, Belgium;b Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons–UMONS, Mons, BelgiumCorrespondence[email protected]
View further author information
, View further author information
Annick Mignonc Medical, Pfizer nv/sa, Brussels, BelgiumView further author information
, Audrey Taelmand Health & Value, Pfizer nv/sa, Brussels, BelgiumView further author information
, Ahuva Averine Health Economics, Policy Analysis Inc. (PAI), Chestnut Hill, MA, USAView further author information
, Mark Atwoode Health Economics, Policy Analysis Inc. (PAI), Chestnut Hill, MA, USAView further author information
& Jeffrey Vietrif Patient & Health Impact, Pfizer Inc, Collegeville, PA, USAView further author information
Pages 1008-1021
|
Received 12 Sep 2023, Accepted 17 Oct 2023, Published online: 02 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.